Q3 2021 Holdings
Filed 2021-11-12 | 148 holdings | $728.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $236.0M | 650,000 | 32.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $174.3M | 577,308 | 23.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $132.2M | 700,000 | 18.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $46.5M | 1,300,000 | 6.4% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $36.9M | 500,000 | 5.1% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $22.1M | 1,000,000 | 3.0% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $14.8M | 100,000 | 2.0% |
| Adagene Inc(ADAG) | ADS | 005329107 | $14.4M | 1,000,000 | 2.0% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $13.9M | 1,646,517 | 1.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $11.7M | 250,000 | 1.6% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $9.7M | 405,347 | 1.3% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $5.0M | 750,000 | 0.7% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $2.4M | 500,000 | 0.3% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $2.3M | 100,000 | 0.3% |
| Avantor Inc(AVTR) | COM | 05352A100 | $2.0M | 50,000 | 0.3% |
| Altice USA Inc(OPTU) | CL A | 02156K103 | $559.0K | 27,000 | 0.1% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $342.4K | 71,178,364 | 0.0% |
| WW Intl Inc(WW6) | COM | 98262P101 | $270.4K | 14,818,300 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $212.3K | 1,200,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $172.1K | 1,000,000 | 0.0% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $164.0K | 4,750,000 | 0.0% |
| Citigroup Inc(C)Call | COM NEW | 172967424 | $140.4K | 2,000,000 | 0.0% |
| Freeport-Mcmoran Inc(FCX)Call | CL B | 35671D857 | $113.9K | 3,500,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $89.8K | 1,585,049 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $88.8K | 1,350,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $85.9K | 1,450,000 | 0.0% |
| Rubius Therapeutics Inc | COM | 78116T103 | $74.3K | 4,155,625 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $70.6K | 2,814,191 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $67.3K | 3,172,221 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $64.4K | 1,950,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $64.0K | 6,696,955 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $63.7K | 375,000 | 0.0% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $59.8K | 825,000 | 0.0% |
| Bristol-Myers Squibb Co(BMY)Call | COM | 110122108 | $59.2K | 1,000,000 | 0.0% |
| Allovir Inc | COM | 019818103 | $58.2K | 2,323,371 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $53.1K | 1,800,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $44.3K | 1,000,000 | 0.0% |
| Omega Therapeutics Inc | COM | 68217N105 | $42.9K | 2,273,530 | 0.0% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $38.3K | 700,000 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $38.1K | 600,000 | 0.0% |
| Merck & Co Inc(MRK)Call | COM | 58933Y105 | $37.6K | 500,000 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $36.9K | 275,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX)Call | COM | 92532F100 | $36.3K | 200,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $32.2K | 5,250,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $29.7K | 2,358,968 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $28.9K | 5,500,000 | 0.0% |
| Talaris Therapeutics Inc | COM | 87410C104 | $28.0K | 2,064,262 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $27.6K | 1,317,954 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $26.9K | 1,500,000 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $26.8K | 994,047 | 0.0% |